185 MBq/ml oplossing voor injectie.

DRUG2 trials

Sponsors

Stichting Amsterdam UMC, Amsterdam UMC Stichting

Conditions

Cancer (all types)post-COVID syndrome

Phase 2

Immune-Related Rheumatological and neurological Adverse Events study (IRRAE study)

RecruitingCTIS2024-516631-27-00

Stichting Amsterdam UMCCancer (all types)

Start: 2023-05-05Target: 495Updated: 2026-01-22

Phase 3

Post-INFECT: Investigating Neuroinflammation and its eFEcts in post-COVID syndrome: an imaging sTudy

Not yet recruitingCTIS2025-522349-23-00

Amsterdam UMC Stichtingpost-COVID syndrome

Target: 65Updated: 2026-06-01